Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study

Authors
Category Primary study
JournalDigestive and Liver Disease
Year 2020
This article has no abstract
Epistemonikos ID: 8161268175e079ab309041a9e091f6dc95e5d4b6
First added on: Feb 11, 2025